| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 12/23/2009 | CN101607979A Pentacylic triterpanes-vitamin C conjugates as well as preparation method and medical application thereof |
| 12/23/2009 | CN101607978A Two novel compounds in gamboge, preparation method and pharmaceutical use |
| 12/23/2009 | CN101607958A Quinazoline compounds |
| 12/23/2009 | CN101607942A Novel imidazolone anti-tumor compound and preparation method thereof |
| 12/23/2009 | CN101607938A Novel isoquinoline anti-tumor compound and preparation method thereof |
| 12/23/2009 | CN101607936A Gimeracil crystal form and preparation method thereof |
| 12/23/2009 | CN101607931A Preparation method of calcitriol |
| 12/23/2009 | CN101607913A 改进的螯合剂缀合物 Improved chelator conjugate |
| 12/23/2009 | CN101607886A Novel wool gonane compound as well as preparation method and anticancer purpose thereof |
| 12/23/2009 | CN101607861A Method for preparing anti-cancer drug elemene from radix curcumae |
| 12/23/2009 | CN101607091A Method for synthesizing dextran-magnetic LDH-fluorouracil magnetic targeting sustained and controlled release tripolymer |
| 12/23/2009 | CN101607087A Combinations of dmxaa and other anti-cancer agents |
| 12/23/2009 | CN101607068A Traditional Chinese medicine pro-liposome injection for treating liver cancer and preparation process thereof |
| 12/23/2009 | CN101607012A Medicine for treating tumor and cancer and preparation method thereof |
| 12/23/2009 | CN101606976A Method for preparing tetrandrine alkaloids by coupling in-situ conversion-adsorptive separation technology |
| 12/23/2009 | CN101606963A Traditional Chinese medicine combination for enhancing disintoxication and improving dyscrasia of cancer patients |
| 12/23/2009 | CN101606957A Formula for treating and preventing arthritis, synovitis and other orthopaedic diseases and complicating diseases |
| 12/23/2009 | CN101606948A Application of small interfering RNA in preparing medicament for treating colon cancer |
| 12/23/2009 | CN101606947A Gemcitabine hydrochloride composition and preparation method thereof |
| 12/23/2009 | CN101606934A Bendamustine hydrochloride compound |
| 12/23/2009 | CN101606933A Dihydro porphin photosensitizer, preparation method and application thereof |
| 12/23/2009 | CN101606907A Fotemustine solid lipid nanoparticle and preparation method thereof |
| 12/23/2009 | CN100572542C Systemic viral/ligand gene delivery system and gene therapy |
| 12/23/2009 | CN100572540C Tuberculosis vaccines including recombinant BCG strains expressing alanine dehydrogenase, serine dehydratase and/or glutamine synthetase |
| 12/23/2009 | CN100572530C Use of L-alpha-lysophosphatidylcholine to obtain the differentiation of monocytes into mature dendritic cells in vitro |
| 12/23/2009 | CN100572399C Ultramicro chito polysaccharide product processing method |
| 12/23/2009 | CN100572382C Heterocyclic compound capable of inversing tumor cell drug tolerance, preparation method and application thereof |
| 12/23/2009 | CN100572363C New imidazole derivative, method for producing the same and use of the same |
| 12/23/2009 | CN100571785C Relativity between AnnexinA3 and drug resistance of platinum type chemical curing medication for cancer |
| 12/23/2009 | CN100571781C Biotinylated pulullan polysaccharide nanometer grains and the preparation method |
| 12/23/2009 | CN100571709C Medicinal composition with anti-tumor synergistic effect |
| 12/23/2009 | CN100571699C Selenophen compound for treating cancer and its medicine composition |
| 12/23/2009 | CN100571698C Extract of valid target in cudrania tricuspidata total flavone and method for preparing the same |
| 12/23/2009 | CN100571691C Antineoplastic patches for external use of bullatacin |
| 12/23/2009 | CN100571681C Zedoary oil nano emulsion and its preparation process |
| 12/23/2009 | CN100571680C Preparation method of compound bitter sophora preparation for injection and medical use thereof |
| 12/23/2009 | CN100571540C Coco alkaline having carcinogenesis suppressing function |
| 12/23/2009 | CA2728976A1 Combinations comprising methotrexate and dhodh inhibitors |
| 12/23/2009 | CA2728763A1 Crkl targeting peptides |
| 12/23/2009 | CA2728739A1 Compositions, methods, and kits for eliciting an immune response |
| 12/23/2009 | CA2728459A1 Immunogenic peptides derived from the midkine protein, as an anticancer vaccine |
| 12/23/2009 | CA2728454A1 Thiazolyl- and oxazolyl-isoquinolinones and methods for using them |
| 12/23/2009 | CA2728408A1 Substituted pyridazine carboxamide compounds as kinase inhibitor compounds |
| 12/23/2009 | CA2728276A1 Combination therapies against cancer |
| 12/23/2009 | CA2728268A1 Cdca1 epitope peptides and vaccines containing the same |
| 12/23/2009 | CA2728194A1 3-(3-pyrimidin-2-ylbenzyl)-1,2,4-triazolo[4,3-b]pyridazine derivatives as met kinase inhibitors |
| 12/23/2009 | CA2728183A1 Compositions with and process for methylmorpholin-substituted pyrido [2,3-d] pryimidines |
| 12/23/2009 | CA2728063A1 Pyrazole compounds 436 |
| 12/23/2009 | CA2727928A1 Inhibitors of janus kinases |
| 12/23/2009 | CA2727889A1 Anti-tumour compositions and methods |
| 12/23/2009 | CA2727862A1 Boronate ester compounds and pharmaceutical compositions thereof |
| 12/23/2009 | CA2727251A1 2 -arylaminoquinazolines for treating proliferative diseases |
| 12/23/2009 | CA2727069A1 Thiophene or thiazole derivatives and their use as pi3k inhibitors |
| 12/23/2009 | CA2727036A1 Triazolopyridine jak inhibitor compounds and methods |
| 12/23/2009 | CA2726844A1 Triazolopyridine jak inhibitor compounds and methods |
| 12/23/2009 | CA2726508A1 Pyridine compounds |
| 12/23/2009 | CA2726164A1 Wnt protein signalling inhibitors |
| 12/23/2009 | CA2725911A1 Methods of treating a meiotic kinesin-associated disease |
| 12/23/2009 | CA2725014A1 Inhibitors of pi3 kinase |
| 12/23/2009 | CA2723279A1 3-substituted-1h-indole compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses |
| 12/22/2009 | US7635774 Benzimidazole derivatives |
| 12/22/2009 | US7635769 Oligoribonucleotide derivatives for specific inhibition of gene expression |
| 12/22/2009 | US7635767 Compositions comprising polynucleotides encoding TACI-immunoglobulin fusion proteins and methods for producing the same |
| 12/22/2009 | US7635757 Nucleotide sequence which hybridizes to the complement of the specific nucleic acid molecule over its full length under conditions of incubation and encodes a polypeptide which costimulates T cell proliferation in vitro |
| 12/22/2009 | US7635712 Salinosporamides and methods for use thereof |
| 12/22/2009 | US7635708 Peroxidase proliferator activated receptor (PPAR) gamma agonists for playing key role in inducing growth arrest by terminal differentiation of actively proliferating PPAR gamma-expressing cells, particularly transformed adipose cells |
| 12/22/2009 | US7635702 Imidazole compounds as transforming growth factor (TGF) inhibitors |
| 12/22/2009 | US7635686 Cancer treatment with a synthetic sequences |
| 12/22/2009 | US7635677 polypeptides related to a receptor to BAFF (a B-cell activating factor belonging to the Tumor Necrosis Factor family, which is associated with theexpression of B-cells and immunoglobulins); this receptor can be employed in the treatment of cancers, lymphomas, autoimmune diseases related to B-cells |
| 12/22/2009 | US7635673 Gene expression inhibition via contacting with tyrphostin; liposomes; drug screening |
| 12/22/2009 | US7635556 Methods for drug discovery, disease treatment, and diagnosis using metabolomics |
| 12/22/2009 | US7635479 comprising fusion protein biodrug as antitumor agent; contains amino acid sequence from prokaryotic organism such as a Listeria species protein, an ActA protein, a Streptolysin protein; immunotherapy |
| 12/22/2009 | US7635475 Diabody-type bispecific antibody |
| 12/22/2009 | US7635472 single chain antibody construct comprising binding domains specific for human CD3 and human CD19; anticarcinogenic biodrug for treating non-Hodgkin lymphoma |
| 12/22/2009 | US7635468 Allogeneic tumor therapeutic agent, a vaccine using allogeneic tumor cells for the therapeutic treatment of tumor diseases, and a method for the making of such a vaccine, and transfected human tumor cells for use as a vaccine |
| 12/22/2009 | US7635467 Mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof |
| 12/22/2009 | US7635464 Selective targeting of apoptotic cells |
| 12/22/2009 | CA2627862C Use of inhibitors of dipeptidyl peptidase iv (dp iv) in combination with inhibitors of alanyl-aminopeptidase (apn) |
| 12/22/2009 | CA2567857C Irinotecan liposome formulation |
| 12/22/2009 | CA2538095C Selective androgen receptor modulators and methods of use thereof |
| 12/22/2009 | CA2535614C Quinazoline analogs as receptor tyrosine kinase inhibitors |
| 12/22/2009 | CA2479674C New therapeutic use of 5-aminoimidazole-4-carboxamide riboside (acadesine) |
| 12/22/2009 | CA2462369C Compositions for delivery of drug combinations |
| 12/22/2009 | CA2454799C Novel dammarane sapogenins, their use as anti-cancer agents, and a process for producing same |
| 12/22/2009 | CA2435921C Method of cancer therapy |
| 12/22/2009 | CA2417282C Method of treating angiogenesis-related disorders using benzoyl phenylacetic acid |
| 12/22/2009 | CA2416527C Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 12/22/2009 | CA2406081C Administration of a thiol-based chemoprotectant compound |
| 12/22/2009 | CA2402421C Clathrate complexes formed by hyaluronic acid derivatives and use thereof as pharmaceuticals |
| 12/22/2009 | CA2371712C Cyclothiocarbamate derivatives as progesterone receptor modulators |
| 12/22/2009 | CA2369587C Solubilized pharmaceutical composition for parenteral administration |
| 12/22/2009 | CA2368108C Thienopyrimidine compounds, their production and use |
| 12/22/2009 | CA2354024C A recombinant vector expressing multiple costimulatory molecules and uses thereof |
| 12/22/2009 | CA2347752C N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them |
| 12/22/2009 | CA2346847C Novel imidazoles with anti-inflammatory activity |
| 12/22/2009 | CA2345297C Synthetic analogs of ecteinascidin-743 |
| 12/22/2009 | CA2330976C Preparation of fused polycyclic alkaloids by ring closure of azomethine ylides, novel compounds thereof and their use as chemotherapeutic agents |
| 12/22/2009 | CA2173839C Transferrin compositions to alleviate the side effects of cytotoxic drugs |
| 12/22/2009 | CA2133833C Method and kit for imaging and treating organs and tissues |
| 12/20/2009 | WO2009156041A2 Thiazolyl piperdine derivatives |